SBC Medical (SBC)
Nasdaq Market Closed
SBC Medical Group Holdings Incorporated is a healthcare management company focused primarily on cosmetic and aesthetic treatment clinics in Japan. Rather than operating solely as a conventional clinic owner, the company provides a broad set of management and support services to affiliated and franchisee medical centers. Its role is to help these clinics attract patients, manage operations, secure supplies, and maintain a consistent service model across locations.
The company’s services cover several practical areas of clinic administration. These include advertising and marketing support across digital channels such as social media, reservation and customer booking systems, recruitment and staff training assistance, and operational support for clinic employees. SBC Medical also assists with property-related needs, including facility rentals, employee housing arrangements, clinic design, construction coordination, and procurement of medical equipment and consumable supplies.
Its revenue is generated mainly from management service arrangements with franchisee clinics. This structure gives the company exposure to demand for cosmetic procedures, dermatology-related aesthetic services, and other elective treatments, while emphasizing brand development, centralized operations, and clinic network support. The business is tied to consumer spending on appearance-related healthcare, where reputation, convenience, marketing efficiency, and patient experience are important competitive factors.
SBC Medical’s focus on Japan distinguishes it from many healthcare services companies listed in the US market. The company operates in a sector where medical professionalism and consumer branding intersect, and where clinics often depend on strong patient acquisition systems and standardized processes. Its core value proposition is to provide the non-clinical infrastructure that allows cosmetic treatment centers to scale and operate more efficiently.
Last updated
- Market Cap
- 314.91M
- P/E
- 7.72
- P/FCF
- 10.56
- P/S
- 1.86
- Enterprise Value
- 188.25M
- Sector
- Health Care
- Industry
- Offices and Clinics of Doctors of Medicine
- Address
- 200 SPECTRUM CENTER DR., IRVINE, CA, 92618
SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok
SBC Medical to Announce 1Q 2026 Financial Results
Presenting on Emerging Growth Conference 88 Day 2 on December 11; Register to live stream
SBC Medical Participated in 4 Investor Conferences in May and June 2025
Participation in “The 113th Congress of Japan Society of Aesthetic Surgery,” May 2025
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 314.91M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 188.25M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 7.72
- P/B
P/B ratio compares a company's share price to its book value per share.
- 1.23
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 1.86
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 2.95
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 1.11
- EPS
- 0.4
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 10.56
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 9.85
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 29.81M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 15.98%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 10.51%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.16
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 3.82
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 3.78
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 2.67
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 150.99K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 3.07
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 43.06M | 39.57M | 43.35M | 43.36M | 47.33M |
| Gross profit | 30.35M | 28.93M | 30.61M | 30.01M | 37.73M |
| Operating income | 17.72M | 12.85M | 15.88M | 14.55M | 24.2M |
| EBITDA | 18.39M | 13.52M | 16.63M | 15.19M | 24.83M |
| Net income | 11.31M | 14.2M | 12.82M | 2.46M | 21.5M |
| Basic EPS | 0.11 | 0.14 | 0.12 | 0.02 | 0.21 |
| Diluted EPS | 0.11 | 0.14 | 0.12 | 0.02 | 0.21 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 388.02M | 380.45M | 321.36M | 315.3M | 284.61M |
| Total liabilities | 117.64M | 117.14M | 73.3M | 70.65M | 58.28M |
| Total equity | 270.38M | 263.3M | 248.06M | 244.65M | 226.32M |
| Cash & equivalents | 167.31M | 163.77M | 127.43M | 152.74M | 132.06M |
| Current assets | 238.78M | 231.22M | 227.2M | 241.34M | 215.1M |
| Current liabilities | 62.57M | 61.12M | 44.58M | 60.68M | 48.47M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 9.23M | 51.96M | -20.88M | -8.34M | 1.93M |
| Investing cash flow | -528.03K | -24.21M | -12.16M | 16.38M | -978.81K |
| Financing cash flow | -1.84M | 19.82M | 11.57M | 7.18M | -280.38K |
| Change in cash | 3.53M | 36.34M | -25.31M | 20.69M | 7.01M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | DEF 14A — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | DEFA14A — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | ARS — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 8-K — SBC Medical Group Holdings Inc | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | PRE 14A — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 8-K — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 10-Q — SBC Medical Group Holdings Inc | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — SBC Medical Group Holdings Inc | View Filing | |
| form 4 | Form 4 — Aikawa Yoshiyuki | View Filing | |
| form 4 | Form 4 — Aikawa Yoshiyuki | View Filing | |
| form 4 | Form 4 — Aikawa Yoshiyuki | View Filing | |
| edgar index | 8-K — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 4 — SBC Medical Group Holdings Inc | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13D/A — SBC Medical Group Holdings Inc | View Filing | |
| form 4 | Form 4 — Aikawa Yoshiyuki | View Filing | |
| form 4 | Form 4 — Aikawa Yoshiyuki | View Filing | |
| form 4 | Form 4 — Aikawa Yoshiyuki | View Filing | |
| edgar index | 424B7 — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 424B7 — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 10-K — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 8-K — SBC Medical Group Holdings Inc | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | SCHEDULE 13G — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | SCHEDULE 13D/A — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 4 — SBC Medical Group Holdings Inc | View Filing | |
| form 4 | Form 4 — Aikawa Yoshiyuki | View Filing | |
| form 4 | Form 4 — Aikawa Yoshiyuki | View Filing | |
| form 4 | Form 4 — Aikawa Yoshiyuki | View Filing | |
| form 4 | Form 4 — Aikawa Yoshiyuki | View Filing | |
| form 4 | Form 4 — Aikawa Yoshiyuki | View Filing | |
| edgar index | 8-K — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 424B3 — SBC Medical Group Holdings Inc | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — SBC Medical Group Holdings Inc | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | EFFECT — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | S-3 — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 8-K — SBC Medical Group Holdings Inc | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 424B3 — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 8-K — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 10-Q — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | DRS — SBC Medical Group Holdings Inc | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — SBC Medical Group Holdings Inc | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 424B3 — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 8-K — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 10-Q — SBC Medical Group Holdings Inc | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 424B3 — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | EFFECT — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | POS AM — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 8-K — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 8-K — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 8-K — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | DEF 14A — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 424B3 — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 8-K — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 10-Q — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | PRE 14A — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 10-K/A — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 10-K/A — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 3 — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 3/A — SBC Medical Group Holdings Inc | View Filing | |
| form 3 | Form 3 — Aikawa Yoshiyuki | View Filing | |
| edgar index | 8-K — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | 424B3 — SBC Medical Group Holdings Inc | View Filing | |
| edgar index | POS EX — SBC Medical Group Holdings Inc | View Filing |